COO vs. WST, ALGN, MMSI, HAE, ICUI, XRAY, QDEL, NEOG, STAA, and CERS
Should you be buying Cooper Companies stock or one of its competitors? The main competitors of Cooper Companies include West Pharmaceutical Services (WST), Align Technology (ALGN), Merit Medical Systems (MMSI), Haemonetics (HAE), ICU Medical (ICUI), DENTSPLY SIRONA (XRAY), QuidelOrtho (QDEL), Neogen (NEOG), STAAR Surgical (STAA), and Cerus (CERS). These companies are all part of the "health care supplies" industry.
Cooper Companies vs. Its Competitors
Cooper Companies (NASDAQ:COO) and West Pharmaceutical Services (NYSE:WST) are both large-cap medical companies, but which is the superior stock? We will contrast the two businesses based on the strength of their dividends, analyst recommendations, profitability, media sentiment, earnings, risk, institutional ownership and valuation.
Cooper Companies currently has a consensus price target of $99.70, indicating a potential upside of 40.11%. West Pharmaceutical Services has a consensus price target of $320.00, indicating a potential upside of 46.25%. Given West Pharmaceutical Services' stronger consensus rating and higher possible upside, analysts plainly believe West Pharmaceutical Services is more favorable than Cooper Companies.
West Pharmaceutical Services has lower revenue, but higher earnings than Cooper Companies. West Pharmaceutical Services is trading at a lower price-to-earnings ratio than Cooper Companies, indicating that it is currently the more affordable of the two stocks.
Cooper Companies has a beta of 0.98, indicating that its share price is 2% less volatile than the S&P 500. Comparatively, West Pharmaceutical Services has a beta of 1.09, indicating that its share price is 9% more volatile than the S&P 500.
West Pharmaceutical Services has a net margin of 16.13% compared to Cooper Companies' net margin of 10.39%. West Pharmaceutical Services' return on equity of 18.23% beat Cooper Companies' return on equity.
24.4% of Cooper Companies shares are held by institutional investors. Comparatively, 93.9% of West Pharmaceutical Services shares are held by institutional investors. 2.0% of Cooper Companies shares are held by insiders. Comparatively, 0.6% of West Pharmaceutical Services shares are held by insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a company will outperform the market over the long term.
In the previous week, West Pharmaceutical Services had 13 more articles in the media than Cooper Companies. MarketBeat recorded 40 mentions for West Pharmaceutical Services and 27 mentions for Cooper Companies. Cooper Companies' average media sentiment score of 0.65 beat West Pharmaceutical Services' score of 0.32 indicating that Cooper Companies is being referred to more favorably in the media.
Summary
West Pharmaceutical Services beats Cooper Companies on 12 of the 17 factors compared between the two stocks.
Get Cooper Companies News Delivered to You Automatically
Sign up to receive the latest news and ratings for COO and its competitors with MarketBeat's FREE daily newsletter.
New MarketBeat Followers Over Time
This chart shows the number of new MarketBeat users adding COO and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Media Sentiment Over Time
This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Cooper Companies Competitors List
Related Companies and Tools
This page (NASDAQ:COO) was last updated on 7/1/2025 by MarketBeat.com Staff
